Loading RHP…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("RHP","financials")Full statements spill as a table. For one cell: =jivedata("RHP","Revenue") or =jivedata("RHP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
RHP • CIK 0001040829
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Operating Income (Loss) | $453,684 | $490,834 | $487,012 | $543,807 |
| InterestExpenseNonoperating | — | $225,395 | $241,270 | $256,447 |
| Investment Income, Interest | $21,423 | $27,977 | $20,299 | $18,170 |
| Gain (Loss) on Extinguishment of Debt | $-2,252 | $-2,479 | $-2,922 | $-2,580 |
| Income (Loss) from Equity Method Investments | $-17,308 | $275 | $-10,025 | $-9,992 |
| Other Nonoperating Gains (Losses) | $3,921 | $2,814 | $1,540 | $1,223 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $248,098 | $294,026 | $254,634 | $294,181 |
| Income Tax Expense (Benefit) | $-93,702 | $13,836 | $7,324 | $14,279 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $341,800 | $280,190 | $247,310 | $279,902 |
| Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Redeemable | $28,465 | $6,760 | $4,919 | $5,576 |
| Noncontrolling Interest in Net Income (Loss) Operating Partnerships, Redeemable | $2,118 | $1,792 | $-1,034 | $2,390 |
| Net Income (Loss) Attributable to Parent | — | — | $243,425 | $271,936 |
| Revenue from Contract with Customer, Excluding Assessed Tax | $2,158,136 | $2,339,226 | $2,577,061 | $2,743,816 |
| Cost of Goods and Services Sold | $1,225,465 | $1,324,752 | $1,441,052 | $1,540,740 |
| General and Administrative Expense | $42,789 | $41,819 | $42,771 | $43,772 |
| Pre-Opening Costs | $1,308 | $4,618 | $2,882 | $3,522 |
| Gain (Loss) on Disposition of Assets | $-469 | $270 | $-1,296 | $-1,296 |
| Depreciation, Depletion and Amortization, Nonproduction | $211,227 | $235,626 | $278,100 | $300,205 |
| Costs and Expenses | $1,704,452 | $1,848,392 | $2,090,049 | $2,200,009 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Property, Plant and Equipment, Net | $3,955,586 | $4,124,382 | $4,970,429 | $5,078,259 |
| Cash and Cash Equivalents, at Carrying Value | $591,833 | $477,694 | $471,421 | $366,125 |
| Restricted Cash and Cash Equivalents | $108,608 | $98,534 | $28,759 | $31,695 |
| Financing Receivable, after Allowance for Credit Loss | $61,760 | $57,801 | $53,503 | $53,634 |
| Accounts Receivable, after Allowance for Credit Loss | $110,029 | $94,184 | $105,903 | $122,120 |
| Deferred Income Tax Assets, Net | $81,624 | $70,511 | $67,669 | $51,150 |
| Prepaid Expense and Other Assets | $154,810 | $178,091 | $196,798 | $211,266 |
| Intangible Assets, Net (Including Goodwill) | — | — | $286,701 | $277,587 |
| Assets | $5,188,537 | $5,217,573 | $6,181,183 | $6,191,836 |
| Debt and Lease Obligation | $3,377,028 | $3,378,396 | $3,976,913 | $3,969,453 |
| Accounts Payable and Accrued Liabilities | $464,720 | $466,571 | $517,708 | $505,529 |
| Dividends Payable | $67,932 | $71,444 | $78,819 | $78,229 |
| Deferred Gain on Sale of Property | $165,174 | $164,658 | $162,901 | $162,541 |
| Operating Lease, Liability | $129,122 | $135,117 | $158,815 | $163,143 |
| Other Liabilities | $66,658 | $66,805 | $74,251 | $77,745 |
| Liabilities | $4,270,634 | $4,282,991 | $4,969,407 | $4,956,640 |
| Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount | $345,126 | $381,945 | $422,691 | $444,096 |
| Common Stock, Value, Issued | $597 | $599 | $630 | $631 |
| Additional Paid in Capital, Common Stock | $1,502,710 | $1,475,211 | $1,722,332 | $1,706,935 |
| Treasury Stock, Common, Value | $20,508 | $23,526 | $26,788 | $27,573 |
| Accumulated Distributions in Excess of Net Income | — | $888,132 | $933,250 | $921,814 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-19,387 | $-15,172 | $-12,772 | $-9,858 |
| Stockholders' Equity Attributable to Parent | $569,153 | $548,980 | $750,152 | $748,321 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $3,624 | $3,657 | $38,933 | $42,779 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $572,777 | $552,637 | $789,085 | $791,100 |
| Preferred Stock, Shares Authorized | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 400,000,000 | 400,000,000 | 400,000,000 | 400,000,000 |
| Common Stock, Shares, Issued | 59,712,000 | 59,903,000 | 63,006,000 | 63,118,000 |
| Treasury Stock, Common, Shares | 668,000 | 696,000 | 730,000 | 738,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $256,111 | $-124,213 | $-76,048 | $-52,885 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $700,441 | $576,228 | $500,180 | $490,140 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $341,800 | $280,190 | $247,310 | $279,902 |
| Net Cash Provided by (Used in) Operating Activities | $557,056 | $576,506 | $590,629 | $691,851 |
| Payments for Capital Improvements | $206,776 | $407,905 | $358,235 | $417,187 |
| Proceeds from Collection of Notes Receivable | $5,903 | $4,060 | $4,385 | $4,385 |
| Payments for (Proceeds from) Other Investing Activities | $9,977 | $6,557 | $18,164 | $406 |
| Net Cash Provided by (Used in) Investing Activities | $-1,012,816 | $-410,402 | $-1,233,972 | $-413,208 |
| Proceeds from Issuance of Long-term Debt | $400,000 | $1,000,000 | $625,000 | $700,000 |
| Payments of Financing Costs | $23,400 | $23,709 | $13,081 | $19,785 |
| Proceeds from Issuance of Common Stock | $395,444 | $395,444 | $275,532 | $275,532 |
| Payments of Ordinary Dividends, Common Stock | $176,001 | $266,114 | $285,576 | $299,586 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $4,386 | $12,300 | $5,537 | $5,494 |
| Proceeds from (Payments for) Other Financing Activities | $-271 | $-81 | $-289 | $578 |
| Net Cash Provided by (Used in) Financing Activities | $711,871 | $-290,317 | $567,295 | $-331,528 |
| Deferred Income Tax Expense (Benefit) | $-95,825 | $10,196 | $2,430 | $9,571 |
| Depreciation, Depletion and Amortization, Nonproduction | $211,227 | $235,626 | $278,100 | $300,205 |
| Amortization of Debt Issuance Costs | $10,663 | $10,655 | $11,926 | $12,671 |
| Income (Loss) from Equity Method Investments | $-17,308 | $275 | $-10,025 | $-9,992 |
| Share-based Payment Arrangement, Noncash Expense | $15,421 | $13,891 | $14,061 | $14,573 |
| Increase (Decrease) in Accounts Receivable | $-21,550 | $-15,845 | $-2,162 | $-6,992 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $41,520 | $13,860 | $12,292 | $53,398 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $6,608 | $3,482 | $-12,323 | $-4,547 |
| Cash and Cash Equivalents, at Carrying Value | $591,833 | $477,694 | $471,421 | $481,584 |
| Restricted Cash and Cash Equivalents | $108,608 | $98,534 | $28,759 | $8,556 |